We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ganymed Pharmaceuticals Announces CE Marking for Solid Tumour Test

News   Sep 11, 2013

 
Ganymed Pharmaceuticals Announces CE Marking for Solid Tumour Test
 
 
 

RELATED ARTICLES

Circulating Tumor Cell Clusters Identified in Head and Neck Cancer Patients

News

Australian study demonstrates the importance of detecting circulating tumor cell clusters using microfluidic technology.

READ MORE

Scientists Develop Platform to Kill Cancer Cells

News

For the first time ever, scientists have shown that a hybrid nanomaterial based on magnetite-gold particles can serve as a universal platform to both detect cancer cells anywhere in the body and to complete targeted deliveries of drugs to these cells.

READ MORE

Blood Test Could Identify Women at Risk for Gestational Diabetes

News

Early screening could allow for lifestyle changes before gestational diabetes develops.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE